How do I implement a more restrictive transfusion trigger of hemoglobin level of 7 g/dL at my hospital?

Transfusion

Volumn 55, Issue 5, 2015, Pages 937-945

  Boral, Leonard I ^a   Bernard, Andrew ^a   Hjorth, Todd ^b   Davenport, Daniel ^a   Zhang, Daoping ^a   MacIvor, Duncan C ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ARTICLE; BLOOD BANK; CONTROLLED STUDY; COST CONTROL; ERYTHROCYTE TRANSFUSION; HEMOGLOBIN BLOOD LEVEL; HOSPITAL; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL STAFF; NURSE; PHYSICIAN; METABOLISM; STANDARDS; STATISTICS AND NUMERICAL DATA;

ERYTHROCYTE TRANSFUSION; HEMOGLOBINS; HOSPITALS; HUMANS;

EID: 84929264212     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12982     Document Type: Article

References (34)

1. Bernard AC, Davenport DL, Chang PK, et al. Intraoperative transfusion of 1 U to 2 U packed red blood cells is associated with increased 30-day mortality, surgical-site infection, pneumonia, and sepsis in general surgery patients. J Am Coll Surg 2009;208:931-937, 7 e1-2; discussion 938-9.
2. Rohde JM, Dimcheff DE, Blumberg N, et al. Healthcare-associated infection after red blood cell transfusion, a systematic review and meta-analysis. JAMA 2014;311:1317-1326.
3. Bennett-Guerrero E, Veldman TH, Doctor A, et al. Evolution of adverse changes in stored RBCs. Proc Natl Acad Sci U S A 2007;104:17063-17068.
4. Shander A, Javidroozi M, Ozawa S, et al. What is really dangerous: anaemia or transfusion? Br J Anaesth 2011;107(S1):i41-i59.
5. Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999;340:409-417.
6. Lacroix J, Hebert PC, Hutchison JS, et al. Transfusion strategies for patients in pediatric intensive care units. N Engl J Med 2007;356:1609-1619.
7. Napolitano LM, Kurek S, Luchette FA, et al. Clinical practice guideline: red blood cell transfusion in adult trauma and critical care. Crit Care Med 2009;37:3124-3157.
8. Marques MB, Polhill SR, Waldrum MR, et al. How we closed the gap between red blood cell utilization and whole blood collections in our institution. Transfusion 2012;52:1857-1867.
9. Goodnough LT, Shander A,. Patient blood management. Anesthesiology 2012;116:1367-1376.
10. Carson JL, Grossman BJ, Kleinman S, et al. Red blood cell transfusion: a clinical practice guideline from the AABB. Ann Intern Med 2012;157:49-58.
11. Shander A, Gross I, Hill S, et al. A new perspective on best transfusion practices. Blood Transfus 2013;11:193-202.
12. Salpeter SR, Buckley JS, Chatterjee S,. Impact of more restrictive blood transfusion strategies on clinical outcomes: a meta-analysis and systematic review. Am J Med 2014;127:124-131. e3.
13. Yerrabothala S, Desrosiers KP, Szczepiorkowski ZM, et al. Significant reduction in red blood cell transfusions in a general hospital after successful implementation of a restrictive transfusion policy supported by prospective computerized order auditing. Transfusion 2014;54:2640-2645.
14. Myhre BA,. The transfusion trigger-the search for a quantitative holy grail. Ann Clin Lab Sci 2001;31:359-364.
15. Consensus conference. Perioperative red blood cell transfusion. JAMA 1988;260:2700-2703.
16. Pape A, Stein P, Horn O, et al. Clinical evidence of blood transfusion effectiveness. Blood Transfus 2009;7:250-258.
17. Weiskopf RB, Viele MK, Feiner J, et al. Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA 1998;279:217-221.
18. Weiskopf RB, Kramer JH, Viele M, et al. Acute severe isovolemic anemia impairs cognitive function and memory in humans. Anesthesiology 2000;92:1646-1652.
19. Viele MK, Weiskopf RB,. What can we learn about the need for transfusion from patients who refuse blood? The experience with Jehovah's Witnesses. Transfusion 1994;34:396-401.
20. Carson JL, Noveck H, Berlin JA, et al. Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion. Transfusion 2002;42:812-818.
21. Tobian AA, Ness PM, Noveck H, et al. Time course and etiology of death in patients with severe anemia. Transfusion 2009;49:1395-1399.
22. Wu WC, Rathore SS, Wang Y, et al. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 2001;345:1230-1236.
23. Hebert PC, Tinmouth A, Corwin HL,. Controversies in RBC transfusion in the critically ill. Chest 2007;131:1583-1590.
24. Rathore SS, Radford MJ, Krumholz HM,. Blood transfusion in patients with acute coronary syndrome. Letter to the editor. JAMA 2005;293:673.
25. Rao SV, Harrington RA, Stamler JS, et al. Blood transfusion in patients with acute coronary syndrome. Reply to Letter to the editor. JAMA 2005;293:673-674.
26. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345:1368-1377.
27. Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013;41:580-637.
28. The ProCESS Investigators. A randomized trial of protocol-based care for early septic shock. N Engl J Med 2014;370:1683-1693.
29. Stonemetz JL, Allen PX, Wasey J, et al. Development of a risk-adjusted blood utilization metric. Transfusion 2014;54:2716-2723.
30. Shander A, Hofmann A, Ozawa S, et al. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion 2010;50:753-765.
31. Shander A, Hofmann A, Gombotz H, et al. Estimating the cost of blood: past, present, and future directions. Best Pract Res Clin Anaesthesiol 2007;21:271-289.
32. Custer B,. The cost of blood: did you pay too much or did you get a good deal? Transfusion 2010;50:742-744.
33. Vamvakas EC, Blajchman MA,. Transfusion-related immunomodulation (TRIM): an update. Blood Rev 2007;21:327-348.
34. Refaai MA, Blumberg N,. Transfusion immunomodulation from a clinical perspective: an update. Expert Rev Hematol 2013;6:653-663.